Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3‐MAML2 fusions

Background The National Comprehensive Cancer Network (NCCN) guidelines recommend considering postoperative radiotherapy (PORT) for completely resected T1/2N0M0 salivary mucoepidermoid carcinomas when they show tumor spillage, perineural invasion, or intermediate/high‐grade histology. CRTC1/3‐MAML2 f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Head & neck 2018-12, Vol.40 (12), p.2565-2573
Hauptverfasser:	Okumura, Yoshihide, Murase, Takayuki, Saida, Kosuke, Fujii, Kana, Takino, Hisashi, Masaki, Ayako, Ijichi, Kei, Shimozato, Kazuo, Tada, Yuichiro, Nibu, Ken‐ichi, Inagaki, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Carcinoma Carcinoma, Mucoepidermoid - pathology Carcinoma, Mucoepidermoid - radiotherapy Carcinoma, Mucoepidermoid - surgery CRTC1/3‐MAML2 Disease-Free Survival DNA, Neoplasm - analysis Female Follow-Up Studies Gene Fusion Head and neck Histology Humans Male Middle Aged mucoepidermoid carcinoma National Comprehensive Cancer Network (NCCN) guidelines postoperative radiotherapy Prognosis Radiation therapy Radiotherapy, Adjuvant Retrospective Studies Salivary Gland Neoplasms - pathology Salivary Gland Neoplasms - radiotherapy Salivary Gland Neoplasms - surgery Sequence Analysis, DNA Surgery T1/2N0M0 Trans-Activators - genetics Transcription Factors - genetics Tumors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!